Thalidomide [clinicaltrials_resource:d11c89dee8174b858155384d3101cfbd]
Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection [clinicaltrials:NCT00000790]A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection [clinicaltrials:NCT00000812]Thalidomide to Treat Oral Lesions in HIV-Infected Patients [clinicaltrials:NCT00001524]Pilot Study of Thalidomide to Treat Sjogren's Syndrome [clinicaltrials:NCT00001599]A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus [clinicaltrials:NCT00001680]Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV [clinicaltrials:NCT00002104]A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome [clinicaltrials:NCT00002127]Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome [clinicaltrials:NCT00002157]Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients [clinicaltrials:NCT00002174]A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART [clinicaltrials:NCT00002392]Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer [clinicaltrials:NCT00038181]An Open Protocol for the Compassionate Use of Thalidomide [clinicaltrials:NCT00081757]Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide [clinicaltrials:NCT00083408]Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally [clinicaltrials:NCT00083538]Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma [clinicaltrials:NCT00083577]DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse [clinicaltrials:NCT00083681]Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia [clinicaltrials:NCT00083694]Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia [clinicaltrials:NCT00083707]D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma [clinicaltrials:NCT00083876]Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy [clinicaltrials:NCT00083902]Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma [clinicaltrials:NCT00155272]Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide [clinicaltrials:NCT00162760]Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma [clinicaltrials:NCT00165217]Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors [clinicaltrials:NCT00165230]Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma [clinicaltrials:NCT00193544]Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease [clinicaltrials:NCT00209014]A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma [clinicaltrials:NCT00226980]Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients [clinicaltrials:NCT00232934]Use of Thalidomide in Chronic Uveitis [clinicaltrials:NCT00314665]PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma [clinicaltrials:NCT00319865]TCD Followed by autoSCT for Newly Diagnosed MM Patients [clinicaltrials:NCT00349115]Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma [clinicaltrials:NCT00367185]Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200 [clinicaltrials:NCT00455910]Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis [clinicaltrials:NCT00469703]
intervention [clinicaltrials_vocabulary:intervention]
Thalidomide [clinicaltrials_resource:d11c89dee8174b858155384d3101cfbd]
Bio2RDF identifier
d11c89dee8174b858155384d3101cfbd
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d11c89dee8174b858155384d3101cfbd
intervention name [clinicaltrials_vocabulary:intervention-name]
Thalidomide
identifier
clinicaltrials_resource:d11c89dee8174b858155384d3101cfbd
title
Thalidomide
@en
type
label
Thalidomide [clinicaltrials_resource:d11c89dee8174b858155384d3101cfbd]
@en